about
Developing a prioritisation framework in an English Primary Care Trust.Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?Effectiveness and cost-effectiveness of a very brief physical activity intervention delivered in NHS Health Checks (VBI Trial): study protocol for a randomised controlled trial.A randomised controlled trial of three very brief interventions for physical activity in primary care.Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379].Patients' use and views of real-time feedback technology in general practice.Controlling hypertension immediately post stroke: a cost utility analysis of a pilot randomised controlled trial.Using economic analyses for local priority setting : the population cost-impact approach.Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol.Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial.Effectiveness of a behavioural intervention to prevent excessive weight gain during infancy (The Baby Milk Trial): study protocol for a randomised controlled trialPragmatic randomised controlled trial to evaluate the effectiveness and cost effectiveness of a multi-component intervention to reduce substance use and risk-taking behaviour in adolescents involved in the criminal justice system: A trial protocol (The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke's Encephalopathy Presenting at the Emergency DepartmentHome-based medication review in older people: is it cost effective?When and how to update systematic reviews: consensus and checklist.Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.A practical guide to value of information analysis.Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort.The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model.Efficient Research Design: Using Value-of-Information Analysis to Estimate the Optimal Mix of Top-down and Bottom-up Costing Approaches in an Economic Evaluation alongside a Clinical Trial.A cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among adolescents aged 13-14 years.Evaluation of telephone first approach to demand management in English general practice: observational study.The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions.Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling.Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care.Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial-Based Cost Data.A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).Leukotriene antagonists as first-line or add-on asthma-controller therapy.The costs to the NHS of multiple births after IVF treatment in the UK.Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS.DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trialDoes self-monitoring and self-management of blood pressure after stroke or transient ischemic attack improve control? TEST-BP, a randomized controlled trialA Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United KingdomExpert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: An Application to Rates of Disease Progression in Undiagnosed and Untreated MelanomaResearch: increasing value, reducing wasteDetermining in-patient diabetes treatment satisfaction in the UK-the DIPSat studyEconomic evaluations based on decision models: A response to Muston et alCost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma
P50
Q25255528-04D6DD63-C30B-41FC-8183-51B0CD37D853Q26830804-6AB60DD9-E8BD-4C74-B3C0-4196C4D1283CQ27333460-DDB9D29E-EF29-4EB1-AAE2-921909141AC6Q30817736-20898207-5FF3-4C91-B1E2-C225008CDF12Q33520810-D9B61086-36C4-4FCF-B588-5E1EF3D96D9DQ33575657-B330DD41-9797-4875-B06E-F901A19BE511Q33693234-22986748-95DD-4537-814D-E5D65F80BB7BQ33784822-FD2AE3DF-3662-4664-9A1E-0DFCA06CE8DDQ34538085-7A554121-75C2-4F49-9087-F4A592E3F7C3Q35089236-21F39256-3F8A-4207-8614-73AF4ACDE67BQ35877943-C07975C5-BDD5-4128-BF02-1126433A84E7Q36075541-E2FA383F-9FCD-4CDD-B0A4-C5BEB8C9E87CQ36127438-A1AFC968-B25A-4302-8D3C-072A7E309DCAQ36305079-8AFFA138-CB35-44A2-93CE-0CB40FF7B0BFQ36686020-2EA2704D-ADD9-4730-8B59-B65BC4D8232FQ36717217-04A1C434-D251-485B-B273-E8CB2AA5229AQ37114403-F91107CE-BB06-4F0D-A1EC-A36960453417Q37799354-11E9065D-7FB1-4F77-BD40-BA3B4C7CAAEBQ39109596-00A39888-4446-4B38-BB2E-DE89AC24A977Q39349129-15CC280D-7870-49C2-A95D-095554F8F4BEQ39443560-8C5EA42A-C798-4295-B7DC-CF279EF44D8CQ40112592-2026A046-8A55-4791-8B2C-41E96A176541Q42172750-837D3EAC-486E-41E2-B2C2-B69F5A73D463Q42364682-C6B91808-B58E-4A16-A710-1AE615B48570Q44180356-5E4CAC05-B86D-4437-A3DA-70D96E910DBCQ47187159-C4F65A5D-46BC-4E61-9BC0-4BF0E1CFABE8Q47204229-610C12C4-0641-45E1-9FDB-183473D4D8F9Q47308359-BEF22B6D-A9F9-4F40-94D2-27ECC25BE3B1Q48675177-1D559802-878B-459A-86F5-3C472D133630Q48679001-5F51C837-2F64-4E07-8023-82A77AE93100Q50118875-A1F405F6-1FBC-424F-A773-1ECDFD428A94Q52802890-288358C2-BD64-4CAF-9039-1457F4221D17Q59133671-FDE20B21-DFFA-416D-AEA7-1B66C27A0D8BQ59391913-9A7578B1-C980-4174-A2F1-E62223D59E00Q59391916-84D249E2-9A6C-412C-BA77-39D72F9A6C0AQ59391917-BCB9B87B-9B77-40D0-BE40-D3011BA952E3Q59391923-0E9AA7EE-F79E-4705-A858-5F5E3723318CQ59391927-6968B74C-CC93-4547-8C8F-1F6DDF783A3AQ59391929-5EA856C9-DD58-43C5-AAC9-968A3EBCBCE5Q59391932-7020B204-6376-4BBD-AAB1-F21F46572987
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ed C Wilson
@ast
Ed C Wilson
@en
Ed C Wilson
@es
Ed C Wilson
@nl
type
label
Ed C Wilson
@ast
Ed C Wilson
@en
Ed C Wilson
@es
Ed C Wilson
@nl
prefLabel
Ed C Wilson
@ast
Ed C Wilson
@en
Ed C Wilson
@es
Ed C Wilson
@nl
P106
P1153
9044084700
P21
P31
P496
0000-0002-8369-1577